Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls

被引:79
作者
Yabe, Daisuke [1 ]
Kuroe, Akira [1 ]
Lee, Soushou [2 ]
Watanabe, Koin [1 ]
Hyo, Takanori [1 ]
Hishizawa, Masahiro [1 ]
Kurose, Takeshi [1 ]
Deacon, Carolyn F. [3 ]
Holst, Jens J. [3 ]
Hirano, Tsutomu [2 ]
Inagaki, Nobuya [4 ]
Seino, Yutaka [1 ]
机构
[1] Kansai Elect Power Hosp, Div Diabet Clin Nutr & Endocrinol, Osaka, Japan
[2] Showa Univ, Sch Med, Dept Diabet Metab & Endocrinol, Tokyo 142, Japan
[3] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark
[4] Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto, Japan
关键词
DPP-4; GIP; GLP-1; GASTRIC-INHIBITORY POLYPEPTIDE; INCRETIN RESPONSES; MELLITUS; INSULIN; GLUCOSE; PLASMA; DEGRADATION; PRODUCTS; EFFICACY; HORMONES;
D O I
10.1111/j.2040-1124.2010.00010.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although glucose-dependent insulinotropic polypeptide (GIP) levels have been characterized previously, GLP-1 levels in Asians remain unclear. Here, we investigate total and intact levels of GLP-1, as well as GIP during oral glucose and meal tolerance tests (OGTT and MTT) in Japanese patients with or without type 2 diabetes (T2DM). Seventeen Japanese healthy controls and 18 age-matched and untreated patients with T2DM of short duration participated in the present study. Fasting levels of total GPL-1 were similar between the two groups (approximately 15 pM), and intact GLP-1 levels were considerably low in both groups (less than 1 pM). In both groups, total GLP-1 reached a peak 30 min after glucose ingestion (30-40 pM), whereas intact GLP-1 levels remained low with no significant peak. In MTT, total and intact GLP-1 showed no obvious peak. The current data indicate that intact GLP-1 levels are considerably low in the Japanese and that meal-induced enhancement of GLP-1 secretion is negligible in the Japanese. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2010.00010.x, 2010)
引用
收藏
页码:56 / 59
页数:4
相关论文
共 26 条
[1]   Efficacy and safety of incretin therapy in type 2 diabetes - Systematic review and meta-analysis [J].
Amori, Renee E. ;
Lau, Joseph ;
Pittas, Anastassios G. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (02) :194-206
[2]   Incretin and islet hormonal responses to fat and protein ingestion in healthy men [J].
Carr, Richard D. ;
Larsen, Marianne O. ;
Winzell, Maria Sorhede ;
Jelic, Katarina ;
Lindgren, Ola ;
Deacon, Carolyn F. ;
Ahren, Bo .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 295 (04) :E779-E784
[3]   Immunoassays for the incretin hormones GIP and GLP-1 [J].
Deacon, Carolyn F. ;
Holst, Jens J. .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (04) :425-432
[4]   Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide [J].
Deacon, CF ;
Nauck, MA ;
Meier, J ;
Hücking, K ;
Holst, JJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) :3575-3581
[5]   The biology of incretin hormones [J].
Drucker, DJ .
CELL METABOLISM, 2006, 3 (03) :153-165
[6]   The physiology of glucagon-like peptide 1 [J].
Holst, Jens Juul .
PHYSIOLOGICAL REVIEWS, 2007, 87 (04) :1409-1439
[7]   Postprandial glucose, insulin, and incretin responses to grain products in healthy subjects [J].
Juntunen, KS ;
Niskanen, LK ;
Liukkonen, KH ;
Poittanen, KS ;
Holst, JJ ;
Mykkänen, HM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 75 (02) :254-262
[8]   Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus [J].
Kikuchi, Masatoshi ;
Abe, Nobuyuki ;
Kato, Mitsutoshi ;
Terao, Shinji ;
Mimori, Nobuyuki ;
Tachibana, Hideo .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (02) :233-240
[9]   THE HETEROGENEITY OF GASTRIC-INHIBITORY POLYPEPTIDE IN PORCINE AND HUMAN GASTROINTESTINAL MUCOSA EVALUATED WITH 5 DIFFERENT ANTISERA [J].
KRARUP, T ;
HOLST, JJ .
REGULATORY PEPTIDES, 1984, 9 (1-2) :35-46
[10]   Incretin-based therapies for type 2 diabetes mellitus [J].
Lovshin, Julie A. ;
Drucker, Daniel J. .
NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (05) :262-269